Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis
/in Dendritic Cells, Hypernephroma, International Publications, Prostate CancerOncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells
/in International Publications, Newcastle Disease VirusCaspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus
/in International Publications, Newcastle Disease Virus, NSCLCOptimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF
/in Dendritic Cells, International PublicationsChronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells
/in Chronic Leukemia, Dendritic Cells, International PublicationsDendritic cells and cutaneous T-cell lymphomas
/in Dendritic Cells, International Publications, Malignant LymphomaEffect of hyperthermia on invasion ability and TGF-β1 expression of breast carcinoma MCF-7 cells
/in Breast Cancer, Hyperthermia, International PublicationsThird generation dendritic cell vaccines for tumor immunotherapy
/in Dendritic Cells, International PublicationsTargeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer